Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study

Administration routes and dosage significantly impact Alzheimer's disease (AD) treatment effectiveness, as compliance in older patients depends on interactions between concomitant treatments, complex dosages, adverse effects, or medication tolerance. This study aims to describe patient and care...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Patient preference and adherence Jg. 19; S. 1105 - 1118
Hauptverfasser:	Piñol Ripoll, Gerard, Salas Carrillo, Mario
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New Zealand Taylor & Francis Ltd 01.01.2025 Dove Dove Medical Press
Schlagworte:	Alzheimer's disease Caregivers Clinical medicine compliance Dementia Geriatrics Neurology Original Research Patients Physicians rivastigmine spain Statistical analysis Transdermal medication transdermal patch twice-weekly posology Spain twice-weekly posology transdermal patch rivastigmine Alzheimer’s disease compliance Spain
ISSN:	1177-889X, 1177-889X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!